When examining soluble and exosomal PD-L1 in patients with melanoma, Cordonnier and colleagues highlighted the fact that exosomal PD-L1 was higher in concentration compared to soluble PD-L1 and that the exosomal form retained immunosuppressive properties. Here, CD274 is linked to melanoma.